EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound

M Betina Pampena iD, Sadia Samer, Elise G Viox, Kevin Nguyen, Claire Deleage, Leticia Kuri-Cervantes iD, James Regan, Vincent H Wu, Steffen Docken iD, Jeffrey T Safrit, Katharine J Bar, Brandon F Keele iD und 3 weitere

Proceedings of the National Academy of Sciences · 2025

DOI: 10.1073/pnas.2501037122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von M Betina Pampena und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104. Hauptthemen laut MEDLINE: Simian Acquired Immunodeficiency Syndrome, CD8-Positive T-Lymphocytes, Simian Immunodeficiency Virus, Immunomodulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Tissue Reservoirs Scientific Working Group in the Penn Center for AIDS Research, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A primary obstacle for HIV elimination is the long-term viral reservoir in lymphoid tissues (LT) that can cause rebound viremia if therapy is stopped. Cytotoxic CD8 + T cells are critical for control of HIV and Simian immunodeficiency virus (SIV) viremia; however, CD8 + T cells that migrate to LT are primarily noncytotoxic, calling into question whether these cells could reduce the viral reservoir on antiretroviral therapy (ART) or control viral replication when therapy is halted. To determine whether CD8 + T cells can inhibit viral replication when retained in LT, we inhibited lymphocyte egress from LTs in ART-treated SIV-infected rhesus macaques (RMs) during analytic treatment interruption (ATI) using the S1PR modulator FTY720 alone or in combination with anti-PD1 antibody (αPD1) and the IL-15 receptor superagonist N-803 to increase cytolytic function. FTY720 retained migrating CD4 + and CD8 + T cells in LT, whereas cytotoxic CD8 + T cells remained in the vasculature. After ATI and viral rebound, activated SIV-specific CD8 + T cells increased in frequency in LT of FTY720-treated RMs but failed to become cytotoxic or control plasma viremia compared to controls, even when combined with αPD1 and N-803. These findings indicate that LT-localized CD8 + T cells alone may be insufficient to delay or prevent plasma viral rebound during ATI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Simian Acquired Immunodeficiency SyndromeCD8-Positive T-LymphocytesSimian Immunodeficiency VirusImmunomodulationAnti-Retroviral AgentsAnimalsMacaca mulattaFingolimod HydrochlorideVirus ReplicationViral LoadViremiaLymphoid TissueCD4-Positive T-Lymphocytes

Stichwörter der Autor:innen

ARTCD8+ T cellsSIVimmunomodulationlymph nodes

Substanzen

Fingolimod HydrochlorideAnti-Retroviral Agents

Autor:innen und Institutionen

  • Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104.
  • Division of Microbiology and Immunology, Emory National Primate Research Center, Emory University, Atlanta, GA 30329.
  • AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD 21701.
  • Infection Analytics Program, Kirby Institute for Infection and Immunity, University of New South Wales, Sydney, NSW 2033, Australia.
  • ImmunityBio, Inc., Culver City, CA 90245.

ORCID-Profile: M Betina Pampena, Leticia Kuri-Cervantes, Steffen Docken, Brandon F Keele, Miles P Davenport, Michael R Betts

Förderung

  • NIAID NIH HHS
  • Tissue Reservoirs Scientific Working Group in the Penn Center for AIDS Research
  • NCI NIH HHS
  • NIH HHS
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
  • HHS | NIH | National Cancer Institute (NCI)
  • Center for AIDS Research at Emory University

Zitieren

APA

Pampena, M. B., Samer, S., Viox, E. G., Nguyen, K., Deleage, C., Kuri-Cervantes, L., Regan, J., Wu, V. H., Docken, S., Safrit, J. T., Bar, K. J., Keele, B. F., Davenport, M. P., Paiardini, M., & Betts, M. R. (2025). Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2501037122

Vancouver

Pampena MB, Samer S, Viox EG, Nguyen K, Deleage C, Kuri-Cervantes L, et al. Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2501037122

BibTeX
@article{Pampena2025,
  author = {Pampena, M Betina and Samer, Sadia and Viox, Elise G and Nguyen, Kevin and Deleage, Claire and Kuri-Cervantes, Leticia and Regan, James and Wu, Vincent H and Docken, Steffen and Safrit, Jeffrey T and Bar, Katharine J and Keele, Brandon F and Davenport, Miles P and Paiardini, Mirko and Betts, Michael R},
  title = {Therapeutic CD8 + T cell tissue retention and immunomodulation during ART interruption fail to prevent SIV rebound},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2501037122}
}
Kostenlos starten →